Search Results
Search for other papers by Samuel M O'Toole in
Google Scholar
PubMed
Search for other papers by Judit Dénes in
Google Scholar
PubMed
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Constantine A Stratakis in
Google Scholar
PubMed
Search for other papers by Márta Korbonits in
Google Scholar
PubMed
). Mutations in any of the four genes encoding the SDH subunits ( SDHx; SDHA, SDHB, SDHC, SDHD ) or its associated assembly factor ( SDHAF2 ) can result in hereditary phaeo/PGL. SDHx mutations are also responsible for some cases of Carney-Stratakis syndrome
Search for other papers by Arthur S Tischler in
Google Scholar
PubMed
Department of Pathology and Laboratory Medicine, Department of Pathology, Department of Pathology, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, Box 802, Boston, Massachusetts 02111, USA
Search for other papers by Ronald R deKrijger in
Google Scholar
PubMed
as both a screening procedure to triage patients who present with a pheochromocytoma or paraganglioma for genetic testing and as an indicator of whether other tumors in those patients are legitimate components of an SDHx -related syndrome or
Human Molecular Genetics, de Duve Institute, Université catholique de Louvain, Brussels, Belgium
Search for other papers by Lucie Evenepoel in
Google Scholar
PubMed
Search for other papers by Raphaël Helaers in
Google Scholar
PubMed
Search for other papers by Laurent Vroonen in
Google Scholar
PubMed
Search for other papers by Selda Aydin in
Google Scholar
PubMed
Search for other papers by Marc Hamoir in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
Search for other papers by Miikka Vikkula in
Google Scholar
PubMed
Cardiology Department, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
Search for other papers by Alexandre Persu in
Google Scholar
PubMed
SDHB and 1 MAX ) ( Fig. 1 ). Using gene expression profiling, PPGLs can be classified in two clusters: Cluster 1 (hypoxia cluster) containing SDHx -, FH - and VHL -related tumors, and Cluster 2 (kinase signaling cluster) including MAX- , NF1
Department of Medical Genetics, Department of Clinical Genetics, University of Cambridge, Cambridge, UK and
Search for other papers by Eamonn R Maher in
Google Scholar
PubMed
were shown to be associated with increased HIF2 stability (transcriptional profiles were available for two tumours and these clustered with the pseudohypoxic group that contained tumours associated with VHL and SDHX mutations). In summary, recent
Search for other papers by Marta Vaquero in
Google Scholar
PubMed
Search for other papers by Anna Macià in
Google Scholar
PubMed
Search for other papers by Carlos Anerillas in
Google Scholar
PubMed
Search for other papers by Ana Velasco in
Google Scholar
PubMed
Search for other papers by Xavier Matias-Guiu in
Google Scholar
PubMed
Search for other papers by Joan Ribera in
Google Scholar
PubMed
Department of Pathology, Universitat de Lleida/Institut de Recerca Biomèdica de Lleida, Lleida, Spain
Search for other papers by Mario Encinas in
Google Scholar
PubMed
clusters characterized by distinct expression signatures ( Gimenez-Roqueplo et al. 2012 ). Cluster 1 (comprising mutations of SDHx , FH , VHL , or HIF2A ( EPAS1 )) presents a pseudo-hypoxia signature characterized by a switch from oxidative
Search for other papers by Yilun Deng in
Google Scholar
PubMed
Search for other papers by Shahida K Flores in
Google Scholar
PubMed
Search for other papers by ZiMing Cheng in
Google Scholar
PubMed
Search for other papers by Yuejuan Qin in
Google Scholar
PubMed
University of Connecticut Carole and Ray Neag Comprehensive Cancer Center, Farmington, Connecticut, USA
Search for other papers by Robin C Schwartz in
Google Scholar
PubMed
Search for other papers by Carl Malchoff in
Google Scholar
PubMed
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Grebe SK Smith SC Erickson LA 2017 Primary renal paragangliomas and renal neoplasia associated with pheochromocytoma/paraganglioma: analysis of von Hippel-Lindau (VHL), succinate dehydrogenase (SDHX) and transmembrane protein 127 (TMEM127
Search for other papers by J Crona in
Google Scholar
PubMed
Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, UniversitätsSpital Zürich, Zürich, Switzerland
Search for other papers by F Beuschlein in
Google Scholar
PubMed
Search for other papers by K Pacak in
Google Scholar
PubMed
Search for other papers by B Skogseid in
Google Scholar
PubMed
gene carriers Mutations in succinate dehydrogenase subunits A–D ( SDHx) were thought to have almost complete penetrance for PPGL. This figure has now been adjusted, a finding of major importance when designing surveillance protocols for healthy
Search for other papers by Aguirre A de Cubas in
Google Scholar
PubMed
Search for other papers by L Javier Leandro-García in
Google Scholar
PubMed
Search for other papers by Francesca Schiavi in
Google Scholar
PubMed
Search for other papers by Veronika Mancikova in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, Familial Cancer Clinic, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Confocal Microscopy Unit, Proteomics Unit, Endocrinology and Nutrition Service, Endocrinology and Nutrition Service, Department of Medical and Surgical Sciences, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Iñaki Comino-Méndez in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, Familial Cancer Clinic, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Confocal Microscopy Unit, Proteomics Unit, Endocrinology and Nutrition Service, Endocrinology and Nutrition Service, Department of Medical and Surgical Sciences, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Lucía Inglada-Pérez in
Google Scholar
PubMed
Search for other papers by Manuel Perez-Martinez in
Google Scholar
PubMed
Search for other papers by Nuria Ibarz in
Google Scholar
PubMed
Search for other papers by Pilar Ximénez-Embún in
Google Scholar
PubMed
Search for other papers by Elena López-Jiménez in
Google Scholar
PubMed
Search for other papers by Agnieszka Maliszewska in
Google Scholar
PubMed
Search for other papers by Rocío Letón in
Google Scholar
PubMed
Search for other papers by Álvaro Gómez Graña in
Google Scholar
PubMed
Search for other papers by Carmen Bernal in
Google Scholar
PubMed
Search for other papers by Cristina Álvarez-Escolá in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, Familial Cancer Clinic, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Confocal Microscopy Unit, Proteomics Unit, Endocrinology and Nutrition Service, Endocrinology and Nutrition Service, Department of Medical and Surgical Sciences, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Cristina Rodríguez-Antona in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, Familial Cancer Clinic, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Confocal Microscopy Unit, Proteomics Unit, Endocrinology and Nutrition Service, Endocrinology and Nutrition Service, Department of Medical and Surgical Sciences, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Giuseppe Opocher in
Google Scholar
PubMed
Search for other papers by Javier Muñoz in
Google Scholar
PubMed
Search for other papers by Diego Megias in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, Familial Cancer Clinic, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Confocal Microscopy Unit, Proteomics Unit, Endocrinology and Nutrition Service, Endocrinology and Nutrition Service, Department of Medical and Surgical Sciences, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Alberto Cascón in
Google Scholar
PubMed
Hereditary Endocrine Cancer Group, Familial Cancer Clinic, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Confocal Microscopy Unit, Proteomics Unit, Endocrinology and Nutrition Service, Endocrinology and Nutrition Service, Department of Medical and Surgical Sciences, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Centro Nacional de Investigaciones Oncológicas, Melchor Fernández Almagro 3, 28029 Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
et al . 2013 , Pacak et al . 2013 , Taieb et al . 2013 , Toledo et al . 2013 , Yang et al . 2013 ). More specifically, ‘cluster 1’, containing VHL - and SDHx -related tumors, is associated with a pseudohypoxic gene signature, while RET
Search for other papers by E Kim in
Google Scholar
PubMed
Search for other papers by E M Rath in
Google Scholar
PubMed
Cancer Genetics, Department of Endocrinology, Faculty of Pharmacy, Australian Nuclear Science and Technology Organisation, Kolling Institute of Medical Research, Royal North Shore Hospital, and University of Sydney, Sydney, New South Wales, Australia
Search for other papers by V H M Tsang in
Google Scholar
PubMed
Search for other papers by A P Duff in
Google Scholar
PubMed
Cancer Genetics, Department of Endocrinology, Faculty of Pharmacy, Australian Nuclear Science and Technology Organisation, Kolling Institute of Medical Research, Royal North Shore Hospital, and University of Sydney, Sydney, New South Wales, Australia
Search for other papers by B G Robinson in
Google Scholar
PubMed
Search for other papers by W B Church in
Google Scholar
PubMed
Search for other papers by D E Benn in
Google Scholar
PubMed
Search for other papers by T Dwight in
Google Scholar
PubMed
Cancer Genetics, Department of Endocrinology, Faculty of Pharmacy, Australian Nuclear Science and Technology Organisation, Kolling Institute of Medical Research, Royal North Shore Hospital, and University of Sydney, Sydney, New South Wales, Australia
Search for other papers by R J Clifton-Bligh in
Google Scholar
PubMed
subjects carrying SDHx mutations ( Lenders et al . 2014 ); however, penetrance of disease is highly variable, which therefore burdens many asymptomatic individuals with lifetime screening for low-risk events ( Benn et al . 2006 ). Genotype
Search for other papers by Patricia L M Dahia in
Google Scholar
PubMed
Search for other papers by Roderick Clifton-Bligh in
Google Scholar
PubMed
Human Cancer Genetics Program, Spanish National Cancer Research Center, Madrid, Spain
Search for other papers by Anne-Paule Gimenez-Roqueplo in
Google Scholar
PubMed
Human Cancer Genetics Program, Spanish National Cancer Research Center, Madrid, Spain
Search for other papers by Mercedes Robledo in
Google Scholar
PubMed
Search for other papers by Camilo Jimenez in
Google Scholar
PubMed
(also known as the Krebs cycle) protein such as SDHx ( SDHA , -B,-C,-D,-F2 ), FH , MDH2 , SLC25A11 , GOT2 , and so on. ( Castro-Vega et al. 2014 , Cascon et al. 2015 , Remacha et al. 2017 , Buffet et al. 2018 ). The subcluster C1A